GSK Investigational Site

Tauberbischofsheim, Baden-Wurttemberg 97941

0 studies enrolling now · 2 studies all time

What they study most

Infections, Rotavirus, Influenza, Rotavirus Vaccines

Studies at this site

• Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks — Completed
• Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in Children — Completed